Shares of Vinco Ventures (NASDAQ: BBIG ) are in focus after the Nasdaq announced it had accepted the company's remediation plan to file on time all of the required periodic reports with the Securities
Vinco Ventures (NASDAQ: BBIG ) is in focus today after the company disclosed in a Form 8-K that it had filed a Plan of Compliance to Nasdaq on Oct. 17 regarding its stock trading under $1 per share. O

BBIG Stock Is Worth Second Look on CEO Switcheroo

10:57am, Wednesday, 12'th Oct 2022
If you like to follow real-life soap operas, then you're invited to take a look at Vinco Ventures (NASDAQ: BBIG ). This company's story involves a takeover attempt, sudden executive-level changes and
Editor's note: This column is part of InvestorPlace.com's Best Stocks for 2022 contest. Thomas Yeung's pick for the contest is POSaBIT (OTCMKTS: POSAF )  stock.

Why Are Energy Stocks Up Today?

01:11pm, Wednesday, 05'th Oct 2022
Source: Oil and Gas Photographer / Shutterstock.com Energy stocks are on the move Wednesday after OPEC+ agreed to cut the amount of oil produced. The organization of oil-producing countries will be cu
Shares of Vinco Ventures (NASDAQ: BBIG ) are in full focus after a legal settlement was reached concerning the company's management hierarchy. BBIG stock has been at the center of attention since July
Source: vincoventures.com Vinco Ventures (NASDAQ: BBIG ) stock is jumping on Wednesday after the company announced a new CEO and the end of a legal battle. According to a company press release, Ross M
Gainers LAVA Therapeutics N.V. (NASDAQ: LVTX) shares jumped 97% to $4.71 after the company and Seagen Inc (NASDAQ: SGEN) announced an exclusive license agreement in which Seagen will work to develop
Where do investors turn in turbulent markets? Investment-grade bonds, says Morgan Stanley.
Gainers RedHill Biopharma Ltd. (NASDAQ: RDHL) rose 31.4% to $0.6525 in pre-market trading after dipping over 20% on Friday. The European Commission, last month, granted Orphan Drug Designation to Red
While Vinco Ventures (NASDAQ: BBIG ) stock languishes in the market graveyard,  some traders continue to dabble in it. Maybe it's as a result of it being a possible gamma short squeeze opportunity (a
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split. InMed Pharmaceuticals Inc. (NASDAQ: INM)
Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65. NeuroBo Phar

US Stocks Open Higher, Dow Surges 300 Points

02:45pm, Friday, 09'th Sep 2022 Benzinga
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday. Following the market opening Friday, the Dow traded up 1.01% to 32,096.33 while the NASDAQ rose 1.65%
It's been a crazy few months for shareholders in Vinco Ventures (NASDAQ: BBIG ). Following a two-week trading halt in August issued by the Nasdaq, shares of BBIG stock more than doubled in the spa
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE